A hierarchy of safety used by the UKHCDO was implemented meaning that for those newly diagnosed with haemophilia, cryoprecipitate was used. Preference was then given to NHS Factor concentrate with US Factor concentrate given as a last resort.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates